Table 4.
siRNA | CDK11 | Cyclin L1α | Cyclin L2α | CK2α | CK2α ′ | CK2β | Caspase 3 – full length | Bcl-xL | Survivin | |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | siCDK11/CK2 | 0.09 ± 0.02 | 3.07 ± 1.56 | 0.73 ± 0.53 | 0.07 ± 0.08 | 0.05 ± 0.06 | 0.03 ± 0.03 | 0.45 ± 0.17 | 0.40 ± 0.38 | 0.73 ± 0.53 |
P <0.0001 | P <0.0001 | P = 0.001 | P <0.0001 | |||||||
siCK2 | 0.98 ± 0.17 | 1.82 ± 0.67 | 0.78 ± 0.45 | 0.07 ± 0.07 | 0.05 ± 0.06 | 0.06 ± 0.04 | 0.85 ± 0.57 | 0.62 ± 0.10 | 0.85 ± 0.33 | |
P <0.0001 | P = 0.001 | P <0.0001 | ||||||||
siCDK11 | 0.04 ± 0.07 | 2.38 ± 0.18 | 0.91 ± 0.49 | 0.88 ± 0.17 | 1.13 ± 0.18 | 1.05 ± 0.15 | 0.57 ± 0.23 | 0.24 ± 0.05 | 0.79 ± 0.21 | |
P <0.0001 | P = 0.022 | |||||||||
siControl | 0.90 ± 0.04 | 1.77 ± 0.31 | 1.44 ± 0.62 | 1.09 ± 0.10 | 0.98 ± 0.26 | 1.14 ± 0.04 | 0.99 ± 0.07 | 0.93 ± 0.32 | 1.02 ± 0.20 | |
SUM-149 | siCDK11/CK2 | 0.44 ± 0.04 | 1.05 ± 0.12 | 1.30 ± 0.48 | 0.06 ± 0.05 | 0.27 ± 0.10 | 0.25 ± 0.14 | 0.45 ± 0.17 | 0.31 ± 0.21 | 0.77 ± 0.33 |
P <0.0001 | P <0.0001 | P = 0.0004 | P = 0.001 | P = 0.036 | P = 0.034 | |||||
siCK2 | 0.86 ± 0.13 | 0.93 ± 0.18 | 1.31 ± 0.52 | 0.08 ± 0.07 | 0.31 ± 0.23 | 0.14 ± 0.07 | 0.55 ± 0.34 | 0.73 ± 0.12 | 1.02 ± 0.10 | |
P <0.0001 | P = 0.0007 | P = 0.0004 | ||||||||
siCDK11 | 0.40 ± 0.16 | 1.04 ± 0.05 | 1.00 ± 0.19 | 1.19 ± 0.14 | 0.96 ± 0.12 | 0.77 ± 0.26 | 0.62 ± 0.23 | 0.54 ± 0.31 | 0.98 ± 0.18 | |
P <0.0001 | ||||||||||
siControl | 0.89 ± 0.12 | 0.89 ± 0.26 | 0.90 ± 0.87 | 1.36 ± 0.27 | 1.05 ± 0.29 | 0.88 ± 0.17 | 0.92 ± 0.24 | 1.08 ± 0.30 | 0.89 ± 0.22 |
All values normalized to actin expression and expressed relative to untreated cells as mean ± standard deviation. P values are listed underneath the corresponding protein expression value for comparison with untreated cells if P <0.05. CDK, cyclin-dependent kinase; CK2, casein kinase 2; siRNA, small interfering RNA.